Predictive Value of the Intestinal Free Fatty Acid Binding Protein in Celiac Disease
dc.contributor.author | Gökçen, Pınar | |
dc.contributor.author | Çakmak, Erol | |
dc.contributor.author | Adalı, Gupse | |
dc.contributor.author | Doğan, Halef Okan | |
dc.contributor.author | Özer, Hatice | |
dc.contributor.author | Ozturk, Oguzhan | |
dc.contributor.author | Doğanay, Hamdi Levent | |
dc.date.accessioned | 2024-10-26T17:41:15Z | |
dc.date.available | 2024-10-26T17:41:15Z | |
dc.date.issued | 2022 | |
dc.department | Sivas Cumhuriyet Üniversitesi | |
dc.description.abstract | Purpose: Non-invasive tests used in the screening and follow-up of celiac disease (CD) are currently below expectations because they show false negatives/positives and are not always correlated with duodenal histology. We aimed to investigate the predictive value of intestinal free fatty acid binding protein (FABP-I) which can easily be released into the circulation in the presence of enterocyte damage in a short time in CD. Methods: This study included 59 patients with CD who were not on gluten free diet (GFD)(n=24) and who were on GFD(n=35) and 52 healthy controls. Demographic variables, complete blood count, ferritin, vitamin D, calcium, phosphorus, vitamin B12, prothrombin time, INR, and serum FABP-I levels were recorded for all groups. Results: There was no difference between the groups in terms of complete blood count, ferritin, calcium, phosphorus, vitamin B12, prothrombin time and INR (all p>0.05). Mean serum FABP-I was determined as 499.2±33.3 ng/L for patients with CD who were not on GFD and as 487.7±48.0 ng/L for who were on GFD, and these values were significantly higher when compared to the healthy controls 432.2±63.8 ng/L(p<0.001). The sensitivity, specificity, positive predictive value, and negative predictive value of FABP-I for a cut-off value of 456.8 ng/L were 84.7%, 69.2%, 10.2% and 61.5%, respectively(AUC=0.785). Conclusion: This study has shown that FABP-I can serve as a non-invasive predictive marker for CD diagnosis. Overlooked diagnosis in serology-negative patients and false serology positivity for reasons other than CD will be prevented with its use in clinical practice since FABP-I directly reflects intestinal damage. | |
dc.identifier.doi | 10.31067/acusaglik.979140 | |
dc.identifier.endpage | 35 | |
dc.identifier.issn | 1309-470X | |
dc.identifier.issn | 1309-5994 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 30 | |
dc.identifier.trdizinid | 482869 | |
dc.identifier.uri | https://doi.org/10.31067/acusaglik.979140 | |
dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/482869 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/24372 | |
dc.identifier.volume | 13 | |
dc.indekslendigikaynak | TR-Dizin | |
dc.language.iso | en | |
dc.relation.ispartof | Acıbadem Üniversitesi Sağlık Bilimleri Dergisi | |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Predictive Value of the Intestinal Free Fatty Acid Binding Protein in Celiac Disease | |
dc.type | Article |